If you’re planning to travel or just due for a flu shot, here are some of your burning questions answered. Plus: find out ...

An intranasal adjuvanted recombinant influenza vaccine appeared to safely prompt a robust response to a range of H5N1 clades, according to a phase I trial. Immune responses among the three groups that ...

A NIHR-backed trial has found that BPZE1, a nasal spray vaccine, can block whooping cough bacteria from colonising the nose ...

A new vaccine being developed for whooping cough could offer better protection and stop the infection spreading, scientists ...

Researchers have developed an intranasal COVID-19 vaccine that enhances the immune system’s response to the virus, providing longer-lasting, greater protection than vaccine injections, even against ...

The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the patient or a caregiver. FluMist, produced by European pharmaceutical company and ...

Flu has come early and experts predict it could be a particularly nasty season, with a new strain circulating.

AstraZeneca (AZN) launches the first FDA-approved influenza vaccine available for self- or caregiver administration, providing a convenient, household-based option for seasonal flu vaccination ...

In hopes of staying ahead of an evolving SARS-Cov-2 virus, scientists turn to intranasal vaccines to trigger mucosal immunity. Issue: Despite huge scientific gains in developing the original group of ...

Current vaccines have greatly diminished the severity of the COVID-19 pandemic, even though they do not entirely prevent infection and transmission, likely due to insufficient immunity in the upper ...

The human papillomavirus (HPV) vaccine is a triumph of modern medicine—but it cannot eliminate an existing infection. Once HPV takes hold, no approved vaccines can stop its progression to cervical ...

In a phase I trial, an intranasal adjuvanted recombinant influenza vaccine appeared to result in response to a range of H5N1 clades. The adjuvanted vaccine elicited seroconversion against clade 2 ...